Shed Adds Foundayo™ to Its Platform, Expanding Oral GLP-1 Access for Patients Nationwide
Eli Lilly's newly FDA-approved once-daily weight loss pill now available through Shed's patient-centered care platform SALT LAKE CITY, April 15, 2026 /PRNewswire/ -- Shed, a leading online health and wellness platform, today announced it is now offering Foundayo™ (orforglipron), Eli Lilly...
View original →